Nephrology

Episodes 49-59 of 59

• 

  RestartResume

  Challenges in the Early Diagnosis of AAV 

  RestartResume

  Challenges in the Early Diagnosis of AAV 

  KDIGO Conversations in Nephrology

  Challenges in the Early Diagnosis of AAV 

  • 

    

    Vladimir Tesar, MD

  • 

    

    Duvuru Geetha, MD

• 

  RestartResume

  Recent Progress in the Treatment of AAV and its Impact on the Outcome of the Patients 

  RestartResume

  Recent Progress in the Treatment of AAV and its Impact on the Outcome of the Patients 

  KDIGO Conversations in Nephrology

  Recent Progress in the Treatment of AAV and its Impact on the Outcome of the Patients 

  • 

    

    Vladimir Tesar, MD

  • 

    

    David Jayne, MD

• 

  RestartResume

  Is There Still Any Role for Plasma Exchange in AAV?

  RestartResume

  Is There Still Any Role for Plasma Exchange in AAV?

  KDIGO Conversations in Nephrology

  Is There Still Any Role for Plasma Exchange in AAV?

  • 

    

    Vladimir Tesar, MD

  • 

    

    Michael Walsh, MD

• 

  RestartResume

  Best Practices in Fluid Management During CKRT

  RestartResume

  Best Practices in Fluid Management During CKRT

  KDIGO Conversations in Nephrology

  Best Practices in Fluid Management During CKRT

  • 

    

    Marlies Ostermann, MD

  • 

    

    Javier Neyra, MD, MSCS

• 

  RestartResume

  The Role of Hemodynamics for AKI and Maintaining Hemodynamic Stability in KRT Patients

  RestartResume

  The Role of Hemodynamics for AKI and Maintaining Hemodynamic Stability in KRT Patients

  KDIGO Conversations in Nephrology

  The Role of Hemodynamics for AKI and Maintaining Hemodynamic Stability in KRT Patients

  • 

    

    Marlies Ostermann, MD

  • 

    

    Rinaldo Bellomo, MBBS, MD, FRACP

• 

  RestartResume

  Best Practices in Nutrition, Drug Management, and Multi-Organ Support in Patients with AKI 

  RestartResume

  Best Practices in Nutrition, Drug Management, and Multi-Organ Support in Patients with AKI 

  KDIGO Conversations in Nephrology

  Best Practices in Nutrition, Drug Management, and Multi-Organ Support in Patients with AKI 

  • 

    

    Marlies Ostermann, MD

  • 

    

    Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP

• 

  RestartResume

  AFFIRM-AHF: Key Takeaways

  RestartResume

  AFFIRM-AHF: Key Takeaways

  Global Heart Failure Academy

  AFFIRM-AHF: Key Takeaways

  • 

    

    Ewa A. Jankowska, MD, PhD, FESC

• 

  RestartResume

  Late-breaking First Response on AFFIRM-AHF

  RestartResume

  Late-breaking First Response on AFFIRM-AHF

  Global Heart Failure Academy

  Late-breaking First Response on AFFIRM-AHF

  • 

    

    Stefan D. Anker, MD, PhD

  • 

    

    Javed Butler, MD

  • 

    

    Ewa A. Jankowska, MD, PhD, FESC

  • 

    

    Josep Comin-Colet, MD, PhD

• 

  RestartResume

  CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy

  RestartResume

  CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy

  Global Heart Failure Academy

  CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy

  • 

    

    Mikhail Kosiborod, MD

• 

  RestartResume

  Mechanisms in Heart Failure: Why Iron Deficiency Matters

  RestartResume

  Mechanisms in Heart Failure: Why Iron Deficiency Matters

  Global Heart Failure Academy

  Mechanisms in Heart Failure: Why Iron Deficiency Matters

• 

  RestartResume

  Balancing RAASi Therapy and Potassium: Understanding How it Works

  RestartResume

  Balancing RAASi Therapy and Potassium: Understanding How it Works

  Global Heart Failure Academy

  Balancing RAASi Therapy and Potassium: Understanding How it Works

• Previous
• 1
• 2
• 3
• 4
• Next